CREATE AN ACCOUNT
The Immune Tolerance Network (ITN) is an international clinical research consortium sponsored by NIAID, NIH. ITN's mission is to advance the clinical application of immune tolerance therapies and biomarker development by performing high quality clinical trials integrated with mechanism-based research with a focus on allergy, transplantation, and autoimmune disease.
ITN TrialShare shares information about ITN's clinical studies and specimen bio-repository. Data and analysis code underlying ITN-published manuscripts are publicly available with the goal of promoting transparency, reproducibility, and scientific collaboration.
Sample Sharing: The ITN has thousands of biological specimens from well-phenotyped study participants that are available for request. An inventory of the available samples and information about submitting a request for specimens are available on ITN TrialShare.
Bio-IT World Best Practices Awards
The awards "recognize organizations for their outstanding innovations and excellence in the use of technologies and novel business strategies that will advance biomedical and translational research, drug development, and/or clinical trials."
National Academy of Sciences Data and Information Challenge
The Academy’s Board on Research Data and Information held the challenge themed “Using Data for the Public Good” created to increase awareness of issues surrounding collection and use of scientific research data.
TrialShare featured in Clinical Informatics News
ITN’s TrialShare wins Honorable Mention at Bio-IT World Best Practices Awards.
MOST VIEWED STUDIES
|Immune Tolerance Network||Help||Home|
|About Us||Terms||Privacy||Contact||Quick Start Guide||User Guide|
|© Immune Tolerance Network|